BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9027771)

  • 1. Membrane biocompatibility in the treatment of acute renal failure: what is the evidence in 1996?
    Jacobs C
    Nephrol Dial Transplant; 1997 Jan; 12(1):38-42. PubMed ID: 9027771
    [No Abstract]   [Full Text] [Related]  

  • 2. Biocompatible membranes in acute renal failure: prospective case-controlled study.
    Shaldon S
    Nephrol Dial Transplant; 1997 Jan; 12(1):235-6. PubMed ID: 9027814
    [No Abstract]   [Full Text] [Related]  

  • 3. Biocompatible membranes in acute renal failure.
    Shaldon S
    Lancet; 1996 Jan; 347(8995):205-6. PubMed ID: 8544586
    [No Abstract]   [Full Text] [Related]  

  • 4. Membrane biocompatibility: clinical significance and therapeutic implications.
    Dumler F; Levin NW
    Int J Artif Organs; 1985 Sep; 8(5):257-62. PubMed ID: 3910591
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of dialyser biocompatibility on recovery from acute renal failure after cadaveric renal transplantation.
    Lang SM; Schiffl H
    Nephrol Dial Transplant; 2000 Jan; 15(1):134-5. PubMed ID: 10607792
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioincompatible membranes place patients with acute renal failure at increased risk of infection.
    Schiffl H; Sitter T; Lang S; König A; Haider M; Held E
    ASAIO J; 1995; 41(3):M709-12. PubMed ID: 8573898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowering plasma levels of complement factor D with AN69 dialysis membranes.
    Strobel WM; Gürke T; Schifferli JA
    J Clin Apher; 1999; 14(4):188-9. PubMed ID: 10611630
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous renal replacement therapy in acute renal failure: membranes for CRRT.
    Jones CH
    Artif Organs; 1998 Jan; 22(1):2-7. PubMed ID: 9456218
    [No Abstract]   [Full Text] [Related]  

  • 9. Using AN69 ST membrane: a dialysis centre experience.
    Maheut H; Lacour F
    Nephrol Dial Transplant; 2001 Jul; 16(7):1519-20. PubMed ID: 11427664
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the choice of membrane important for patients with acute renal failure requiring hemodialysis?
    Splendiani G; Mazzarella V
    Artif Organs; 1996 Mar; 20(3):281. PubMed ID: 8694703
    [No Abstract]   [Full Text] [Related]  

  • 11. Polyacrilonytrile versus cuprophan membranes for hemodialysis: evaluation of efficacy and biocompatibility by platelet aggregation studies.
    Berrettini M; Buoncristiani U; Parise P; Ballatori E; Nenci GG
    Int J Artif Organs; 1981 Sep; 4(5):218-22. PubMed ID: 7319659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different types of dialyzer membranes: does the bio(in)compatibility matter in the treatment of ARF?
    Vanholder R; Lameire N; Hoste E; Van Loo A; Dhondt AM; Ringoir S
    Ren Fail; 1996 May; 18(3):471-9. PubMed ID: 8827993
    [No Abstract]   [Full Text] [Related]  

  • 13. Concomitant renal and hepatic failure treated by polyacrylonitrile membrane hemodialysis.
    Strand V; Mayor G; Ristow G; Greenbaum D; Mayle J; Rosenbaum R
    Int J Artif Organs; 1981 May; 4(3):136-9. PubMed ID: 7275343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acrylonitrile-sodium methallylsulfonate copolymer. DSC approach to membrane porosity of foam and hollow fibers.
    Cohen-Addad JP; Prunelet A; Bazile JP; Buda A; Thomas M
    Biomaterials; 2003 Jan; 24(1):173-9. PubMed ID: 12417191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AN69ST dialysis membrane. A new approach for reducing systemic heparinization.
    Renaux JL; Atti M
    Contrib Nephrol; 2002; (137):111-9. PubMed ID: 12101943
    [No Abstract]   [Full Text] [Related]  

  • 16. AN69-ST membrane, a useful option in two cases of severe dialysis reactions.
    Cerqueira A; Martins PA; Carvalho BA; Vasconcelos MP
    Clin Nephrol; 2015 Feb; 83(2):100-3. PubMed ID: 25208312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eicosanoid release as an indicator of membrane biocompatibility.
    Schultze G; Wagner K; Neumayer HH; Molzahn M
    Contrib Nephrol; 1987; 59():44-50. PubMed ID: 3442987
    [No Abstract]   [Full Text] [Related]  

  • 18. Absence of anaphylactoid reactions with the combined use of ACE inhibitors and AN69 hemodialysis membranes.
    Mazuecos A; Montoyo C; Andres A; Campo C; Praga M
    Nephron; 1991; 59(3):519. PubMed ID: 1758555
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical implications of hemodialysis membrane biocompatibility.
    Hakim RM
    Kidney Int; 1993 Sep; 44(3):484-94. PubMed ID: 8231020
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient survival on PAN/AN69 membrane hemodialysis: a ten-year analysis.
    Chandran PK; Liggett R; Kirkpatrick B
    J Am Soc Nephrol; 1993 Nov; 4(5):1199-204. PubMed ID: 8305647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.